Abstract
Drug allergy delabeling programs have become an essential element of antibiotic stewardship. Development of delabeling programs involves careful selection of target patient population, thoughtful design of delabeling approach, stakeholder engagement, assembly of key team members, implementation, and evaluation of clinical and safety outcomes. Recent programs have targeted patients thought to be most likely to benefit from removal of inaccurate antibiotic allergy labels, those with β-lactam antibiotic allergies and high-risk populations likely to need β-lactam antibiotics as first-line treatment. This review provides an overview of current risk stratification methods and β-lactam cross-reactivity data and summarizes how different inpatient and outpatient delabeling programs have used these concepts in delabeling algorithms. β-Lactam delabeling programs for inpatients, pediatric patients, and programs utilizing telehealth have been implemented with good outcomes. This review also focuses on delabeling programs for high-risk populations likely to benefit from first-line β-lactam antibiotics. These populations include perioperative, prenatal, and immunocompromised patients. Delabeling programs have been successful in the inpatient and outpatient settings at enabling appropriate antibiotic use. This article reviews delabeling strategies utilized by these programs with a focus on highlighting elements key to their success and future areas for innovation.
Similar content being viewed by others
Data Availability
Not applicable.
Code Availability
Not applicable.
Abbreviations
- A/I:
-
Allergy/immunology
- AAAAI:
-
American Academy of Allergy Asthma Immunology
- ACOG:
-
American College of Obstetricians and Gynecologists
- ADR:
-
Adverse drug reaction
- ASP:
-
Antimicrobial stewardship program
- β-Lactam:
-
Beta-lactam
- CDC:
-
Centers for Disease Control and Prevention
- C. diff :
-
Clostridium difficile
- CF:
-
Cystic fibrosis
- C-section:
-
Cesarean section
- EHR:
-
Electronic health record
- GBS:
-
Group B Streptococcus
- HIV:
-
Human immunodeficiency virus
- HSCT:
-
Hematopoietic stem cell transplant
- HSR:
-
Hypersensitivity reaction
- ID:
-
Infectious disease
- IDSA:
-
Infectious Diseases Society of America
- IV:
-
Intravenous
- MRSA:
-
Methicillin-resistant Staphylococcus aureus
- PA:
-
Penicillin allergy
- PCN:
-
Penicillin
- PJP:
-
Pneumocystis jirovecii Pneumonia
- PPROM:
-
Preterm premature rupture of membranes
- RA:
-
Rheumatoid arthritis
- SLE:
-
Systemic lupus erythematosus
- SJS/TEN:
-
Stevens–Johnson syndrome/toxic epidermal necrolysis
- ST:
-
Skin test
- UK:
-
United Kingdom
- US:
-
United States
- VRE:
-
Vancomycin-resistant enterococcus
References
Joint Commission on Hospital Accreditation (2016) APPROVED: new antimicrobial stewardship standard. Jt Comm Perspect 36(7):1, 3–4, 8
Shenoy ES, Macy E, Rowe T, Blumenthal KG (2019) Evaluation and management of penicillin allergy: a review. JAMA 321(2):188–199
Macy E (2014) Penicillin and beta-lactam allergy: epidemiology and diagnosis. Curr Allergy Asthma Rep 14(11):476
Albin S, Agarwal S (2014) Prevalence and characteristics of reported penicillin allergy in an urban outpatient adult population. Allergy Asthma Proc 35(6):489–94
Macy E, Ngor EW (2013) Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine, penicillin, and oral amoxicillin. J Allergy Clin Immunol Pract 1(3):258–63
Rimawi RH, Cook PP, Gooch M, Kabchi B, Ashraf MS, Rimawi BH, Gebregziabher M, Siraj DS (2013) The impact of penicillin skin testing on clinical practice and antimicrobial stewardship. J Hosp Med 8(6):341–345
Macy E, Contreras R (2014) Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: a cohort study. J Allergy Clin Immunol 133(3):790–796
Blumenthal KG, Lu N, Zhang Y, Li Y, Walensky RP, Choi HK (2018) Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study. BMJ 361:k2400
Picard M, Bégin P, Bouchard H, Cloutier J, Lacombe-Barrios J, Paradis J, Des Roches A, Laufer B, Paradis L (2013) Treatment of patients with a history of penicillin allergy in a large tertiary-care academic hospital. J Allergy Clin Immunol Pract 1(3):252–7
Blumenthal KG, Ryan EE, Li Y, Lee H, Kuhlen JL, Shenoy ES (2018) The impact of a reported penicillin allergy on surgical site infection risk. Clin Infect Dis 66(3):329–336
Lee CE, Zembower TR, Fotis MA, Postelnick MJ, Greenberger PA, Peterson LR, Noskin GA (2000) The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance. Arch Intern Med 160(18):2819–2822
MacLaughlin EJ, Saseen JJ, Malone DC (2000) Costs of beta-lactam allergies: selection and costs of antibiotics for patients with a reported beta-lactam allergy. Arch Fam Med 9(8):722–726
Sade K, Holtzer I, Levo Y, Kivity S (2003) The economic burden of antibiotic treatment of penicillin-allergic patients in internal medicine wards of a general tertiary care hospital. Clin Exp Allergy 33(4):501–506
MacFadden DR, LaDelfa A, Leen J, Gold WL, Daneman N, Weber E, Al-Busaidi I, Petrescu D, Saltzman I, Devlin M, Andany N, Leis JA. Impact of reported beta-lactam allergy on inpatient outcomes: a multicenter prospective cohort study
American Academy of Allergy, Asthma & Immunology Choosing Wisely: ten things physicians and patients should question. Available at: https://www.choosingwisely.org/clinician-lists/american-academy-allergy-asthma-immunlogy-non-beta-lactam-antibiotics-penicillin-allergy/. Accessed 26 July, 2021
Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, Srinivasan A, Dellit TH, Falck-Ytter YT, Fishman NO, Hamilton CW, Jenkins TC, Lipsett PA, Malani PN, May LS, Moran GJ, Neuhauser MM, Newland JG, Ohl CA, Samore MH, Seo SK, Trivedi KK (2016) Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 62(10):e51-77
Evaluation and diagnosis of penicillin allergy for healthcare professionals. Available at: https://www.cdc.gov/antibiotic-use/community/for-hcp/Penicillin-Allergy.html. Accessed 26 July, 2021
Prevention of group B streptococcal early-onset disease in newborns: ACOG Committee Opinion (2020) Number 797. Obstet Gynecol 135(2):e51-e72
Tucker MH, Lomas CM, Ramchandar N, Waldram JD (2017) Amoxicillin challenge without penicillin skin testing in evaluation of penicillin allergy in a cohort of marine recruits. J Allergy Clin Immunol Pract 5(3):813–815
Kotas RV, Wells TJ, Mims LC, Trainor EJ, Wiles CL (1975) A new model for neonatal pulmonary hemorrhage research. Pediatr Res 9(4):161–165
Iammatteo M, Alvarez Arango S, Ferastraoaru D, Akbar N, Lee AY, Cohen HW, Jerschow E (2019) Safety and outcomes of oral graded challenges to amoxicillin without prior skin testing. J Allergy Clin Immunol Pract 7(1):236–243
Blumenthal KG, Huebner EM, Fu X, Li Y, Bhattacharya G, Levin AS, Mancini CM, Slawski BR, Banerji A (2019) Risk-based pathway for outpatient penicillin allergy evaluations. J Allergy Clin Immunol Pract 7(7):2411–2414.e1
Ramsey A, Mustafa SS, Holly AM, Staicu ML (2020) Direct challenges to penicillin-based antibiotics in the inpatient setting. J Allergy Clin Immunol Pract 8(7):2294–2301
Stevenson B, Trevenen M, Klinken E, Smith W, Yuson C, Katelaris C, Perram F, Burton P, Yun J, Cai F, Barnes S, Spriggs K, Ojaimi S, Mullins R, Salman S, Martinez P, Murray K, Lucas M (2020) Multicenter Australian study to determine criteria for low- and high-risk penicillin testing in outpatients. J Allergy Clin Immunol Pract 8(2):681-689.e3
Mill C, Primeau MN, Medoff E, Lejtenyi C, O'Keefe A, Netchiporouk E, Dery A, Ben-Shoshan M (2016) Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children. JAMA Pediatr 170(6):e160033
Allen HI, Vazquez-Ortiz M, Murphy AW, Moylett EM (2020) De-labeling penicillin-allergic children in outpatients using telemedicine: potential to replicate in primary care. J Allergy Clin Immunol Pract 8(5):1750–1752
Vyles D, Chiu A, Routes J, Castells M, Phillips EJ, Visotcky A, Fraser R, Pezzin L, Brousseau DC (2020) Oral amoxicillin challenges in low-risk children during a pediatric emergency department visit. J Allergy Clin Immunol Pract 8(3):1126-1128.e1
Zhang BY, Paquette V, McClymont E, Barlas A, Wong T, Watt M, Mak R, Elwood C (2021) Implementing a penicillin allergy delabeling service for the obstetric population. J Allergy Clin Immunol Pract 9(6):2501-2502.e2
Trubiano JA, Smibert O, Douglas A, Devchand M, Lambros B, Holmes NE, Chua KY, Phillips EJ, Slavin MA (2018) The safety and efficacy of an oral penicillin challenge program in cancer patients: a multicenter pilot study. Open Forum Infect Dis 5(12):ofy306
Trubiano JA, Vogrin S, Chua KYL, Bourke J, Yun J, Douglas A, Stone CA, Yu R, Groenendijk L, Holmes NE, Phillips EJ (2020) Development and validation of a penicillin allergy clinical decision rule. JAMA Intern Med 180(5):745–752
Joint Task Force on Practice Parameters (2010) American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 105(4):259–273
Solensky R, Jacobs J, Lester M, Lieberman P, McCafferty F, Nilsson T, Park M, Schwarz G, Soong W, Wagelie-Steffen A, Wedner HJ, Weiss M, Windom H, Tonascia J, Yates KP, Mendelson LM, Wolfe J, Adkinson NF (2019) Penicillin allergy evaluation: a prospective, multicenter, open-label evaluation of a comprehensive penicillin skin test kit. J Allergy Clin Immunol Pract 7(6):1876–1885.e3
Devchand M, Urbancic KF, Khumra S, Douglas AP, Smibert O, Cohen E, Sutherland M, Phillips EJ, Trubiano JA (2019) Pathways to improved antibiotic allergy and antimicrobial stewardship practice: the validation of a beta-lactam antibiotic allergy assessment tool. J Allergy Clin Immunol Pract 7(3):1063-1065.e5
Chua KYL, Vogrin S, Bury S, Douglas A, Holmes NE, Tan N, Brusco NK, Hall R, Lambros B, Lean J, Stevenson W, Devchand M, Garrett K, Thursky K, Grayson ML, Slavin MA, Phillips EJ, Trubiano JA (2020) The penicillin allergy delabeling program: a multicenter whole-of-hospital health services intervention and comparative effectiveness study. Clin Infect Dis. ciaa653
Khan DA, Banerji A, Bernstein JA, Bilgicer B, Blumenthal K, Castells M, Ein D, Lang DM, Phillips E (2019) Cephalosporin allergy: current understanding and future challenges. J Allergy Clin Immunol Pract 7(7):2105–2114
Romano A, Valluzzi RL, Caruso C, Maggioletti M, Quaratino D, Gaeta F (2018) Cross-reactivity and tolerability of cephalosporins in patients with IgE-mediated hypersensitivity to penicillins. J Allergy Clin Immunol Pract 6(5):1662–1672
Romano A, Valluzzi RL, Caruso C, Zaffiro A, Quaratino D, Gaeta F (2020) Tolerability of cefazolin and ceftibuten in patients with IgE-mediated aminopenicillin allergy. J Allergy Clin Immunol Pract 8(6):1989-1993.e2
Anstey KM, Anstey JE, Doernberg SB, Chen LL, Otani IM (2021) Perioperative use and safety of cephalosporin antibiotics in patients with documented penicillin allergy. J Allergy Clin Immunol Pract S2213–2198(21):00323–00328
Blumenthal KG, Shenoy ES, Varughese CA, Hurwitz S, Hooper DC, Banerji A (2015) Impact of a clinical guideline for prescribing antibiotics to inpatients reporting penicillin or cephalosporin allergy. Ann Allergy Asthma Immunol 115(4):294-300.e2
Blumenthal KG, Shenoy ES, Wolfson AR, Berkowitz DN, Carballo VA, Balekian DS, Marquis KA, Elshaboury R, Gandhi RG, Meka P, Kubiak DW, Catella J, Lambl BB, Hsu JT, Freeley MM, Gruszecki A, Wickner PG (2017) Addressing inpatient beta-lactam allergies: a multihospital implementation. J Allergy Clin Immunol Pract 5(3):616–625.e7
King EA, Challa S, Curtin P, Bielory L (2016) Penicillin skin testing in hospitalized patients with β-lactam allergies: effect on antibiotic selection and cost. Ann Allergy Asthma Immunol 117(1):67–71
Estep PM, Ferreira JA, Dupree LH, Aldridge PJ, Jankowski CA (2016) Impact of an antimicrobial stewardship initiative to evaluate β-lactam allergy in patients ordered aztreonam. Am J Health Syst Pharm 73(5 Suppl 1):S8-13
Chen JR, Tarver SA, Alvarez KS, Tran T, Khan DA (2017) A proactive approach to penicillin allergy testing in hospitalized patients. J Allergy Clin Immunol Pract. 5(3):686–693. https://doi.org/10.1016/j.jaip.2016.09.045
Heil EL, Bork JT, Schmalzle SA, Kleinberg M, Kewalramani A, Gilliam BL, Buchwald UK (2016) Implementation of an infectious disease fellow-managed penicillin allergy skin testing service. Open Forum Infect Dis 3(3):ofw155
Sigona NS, Steele JM, Miller CD (2016) Impact of a pharmacist-driven beta-lactam allergy interview on inpatient antimicrobial therapy: a pilot project. J Am Pharm Assoc (2003) 56(6):665–669
Staicu ML, Brundige ML, Ramsey A, Brown J, Yamshchikov A, Peterson DR, Baran A, Laguio-Vila M (2016) Implementation of a penicillin allergy screening tool to optimize aztreonam use. Am J Health Syst Pharm 73(5):298–306
Swearingen SM, White C, Weidert S, Hinds M, Narro JP, Guarascio AJ (2016) A multidimensional antimicrobial stewardship intervention targeting aztreonam use in patients with a reported penicillin allergy. Int J Clin Pharm 38(2):213–217
Blumenthal KG, Wickner PG, Hurwitz S, Pricco N, Nee AE, Laskowski K, Shenoy ES, Walensky RP (2017) Tackling inpatient penicillin allergies: assessing tools for antimicrobial stewardship. J Allergy Clin Immunol 140(1):154-161.e6
Ramsey A, Staicu ML (2018) Use of a penicillin allergy screening algorithm and penicillin skin testing for transitioning hospitalized patients to first-line antibiotic therapy. J Allergy Clin Immunol Pract 6(4):1349–1355
Devchand M, Kirkpatrick CMJ, Stevenson W, Garrett K, Perera D, Khumra S, Urbancic K, Grayson ML, Trubiano JA (2019) Evaluation of a pharmacist-led penicillin allergy de-labelling ward round: a novel antimicrobial stewardship intervention. J Antimicrob Chemother 74(6):1725–1730
du Plessis T, Walls G, Jordan A, Holland DJ (2019) Implementation of a pharmacist-led penicillin allergy de-labelling service in a public hospital. J Antimicrob Chemother 74(5):1438–1446
Harmon S, Richardson T, Simons H, Monforte S, Fanning S, Harrington K (2020) The clinical and financial impact of a pharmacist-driven penicillin skin testing program on antimicrobial stewardship practices. Hosp Pharm 55(1):58–63
Blumenthal KG, Li Y, Hsu JT, Wolfson AR, Berkowitz DN, Carballo VA, Schwartz JM, Marquis KA, Elshaboury R, Gandhi RG, Lambl BB, Freeley MM, Gruszecki A, Wickner PG, Shenoy ES (2019) Outcomes from an inpatient beta-lactam allergy guideline across a large US health system. Infect Control Hosp Epidemiol 40(5):528–535
Sacco KA, Cochran BP, Epps K, Parkulo M, Gonzalez-Estrada A (2019) Inpatient β-lactam test-dose protocol and antimicrobial stewardship in patients with a history of penicillin allergy. Ann Allergy Asthma Immunol 122(2):184–188
Wall GC, Peters L, Leaders CB, Wille JA (2004) Pharmacist-managed service providing penicillin allergy skin tests. Am J Health Syst Pharm 61(12):1271–1275
Lucas M, Arnold A, Sommerfield A, Trevenen M, Braconnier L, Schilling A, Abass F, Slevin L, Knezevic B, Blyth C, Murray K, von Ungern-Sternberg B, Rueter K (2019) Antibiotic allergy labels in children are associated with adverse clinical outcomes. J Allergy Clin Immunol Pract 7(3):975–982
Ibia EO, Schwartz RH, Wiedermann BL (2000) Antibiotic rashes in children: a survey in a private practice setting. Arch Dermatol 136(7):849–854
Blanca-López N, Zapatero L, Alonso E, Torres MJ, Fuentes V, Martínez-Molero MI, Blanca M (2009) Skin testing and drug provocation in the diagnosis of nonimmediate reactions to aminopenicillins in children. Allergy 64(2):229–233
Zambonino MA, Corzo JL, Muñoz C, Requena G, Ariza A, Mayorga C, Urda A, Blanca M, Torres MJ (2014) Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children. Pediatr Allergy Immunol 25(1):80–87
Caubet JC, Frossard C, Fellay B, Eigenmann PA (2015) Skin tests and in vitro allergy tests have a poor diagnostic value for benign skin rashes due to β-lactams in children. Pediatr Allergy Immunol 26(1):80–82
Confino-Cohen R, Rosman Y, Meir-Shafrir K, Stauber T, Lachover-Roth I, Hershko A, Goldberg A (2017) Oral challenge without skin testing safely excludes clinically significant delayed-onset penicillin hypersensitivity. J Allergy Clin Immunol Pract 5(3):669–675
Staicu ML, Holly AM, Conn KM, Ramsey A (2018) The use of telemedicine for penicillin allergy skin testing. J Allergy Clin Immunol Pract 6(6):2033–2040
Wolfson AR, Mancini CM, Banerji A, Fu X, Bryant AS, Phadke NA, Shenoy ES, Arman W, Zhang Y, Blumenthal KG (2021) Penicillin allergy assessment in pregnancy: safety and impact on antibiotic use. J Allergy Clin Immunol Pract 9(3):1338–1346
Blumenthal KG, Shenoy ES, Hurwitz S, Varughese CA, Hooper DC, Banerji A (2014) Effect of a drug allergy educational program and antibiotic prescribing guideline on inpatient clinical providers’ antibiotic prescribing knowledge. J Allergy Clin Immunol Pract 2(4):407–13
Stukus DR, Green T, Montandon SV, Wada KJ (2015) Deficits in allergy knowledge among physicians at academic medical centers. Ann Allergy Asthma Immunol 115(1):51-55.e1
Lutfeali S, DiLoreto FF, Alvarez KS, Patel SV, Joshi SR, Tarver SA, Khan DA (2021) Maintaining penicillin allergy delabeling: a quality improvement initiative. J Allergy Clin Immunol Pract 9(5):2104-2106.e2
Lachover-Roth I, Sharon S, Rosman Y, Meir-Shafrir K, Confino-Cohen R (2019) Long-term follow-up after penicillin allergy delabeling in ambulatory patients. J Allergy Clin Immunol Pract 7(1):231-235.e1
Warrington RJ, Lee KR, McPhillips S (2000) The value of skin testing for penicillin allergy in an inpatient population: analysis of the subsequent patient management. Allergy Asthma Proc 21(5):297–9
Gerace KS, Phillips E (2015) Penicillin allergy label persists despite negative testing. J Allergy Clin Immunol Pract 3(5):815–6
Rimawi RH, Shah KB, Cook PP (2013) Risk of redocumenting penicillin allergy in a cohort of patients with negative penicillin skin tests. J Hosp Med 8(11):615–8
Moussa Y, Sullivan A, Matte G, Goldstein RH, Baldini G, Shuster J, Tsoukas C (2020) Impact of persistent β-lactam allergy documentation despite delabeling in the perioperative setting. J Allergy Clin Immunol Pract 8(1):411–412
Savic L, Thomas C, Fallaha D, Wilson M, Hopkins PM, Savic S, Clark SH (2020) RAFT group. DALES, Drug Allergy Labels in Elective Surgical patients: a prospective multicentre cross-sectional study of incidence, risks, and attitudes in penicillin de-labelling strategies. Br J Anaesth 125(6):962–969
Taremi M, Artau A, Foolad F, Berlin S, White C, Jiang Y, Raad I, Adachi J (2019) Safety, efficacy, and clinical impact of penicillin skin testing in immunocompromised cancer patients. J Allergy Clin Immunol Pract 7(7):2185–2191.e1
Desravines N, Waldron J, Venkatesh KK, Kwan M, Boggess KA (2021) Outpatient penicillin allergy testing in pregnant women who report an allergy. Obstet Gynecol 137(1):56–61
Anstey KM, Choi L, Dawson D, Kleinhenz ME, Otani IM (2021) Enabling antibiotic allergy evaluations and reintroduction of first-line antibiotics for patients with cystic fibrosis. Ann Allergy Asthma Immunol S1081–1206(21):00412–00419
Petroni DH, Aitken ML, Ham E, Chung S, Menalia L, Altman MC, Ayars AG (2016) Approach to the evaluation of adverse antibiotic reactions in patients with cystic fibrosis. Ann Allergy Asthma Immunol 117(4):378–381
Brown M, Uzoma J, Vansice R, Mahan K, Conn KM, Ramsey A, Staicu ML (2021) Examining the impact of a penicillin allergy skin testing brochure on inpatient perceptions: a pre-post intervention study. J Allergy Clin Immunol Pract 9(4):1736-1737.e3
Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, Fish DN, Napolitano LM, Sawyer RG, Slain D, Steinberg JP, Weinstein RA (2013) American Society of Health-System Pharmacists; Infectious Disease Society of America; Surgical Infection Society; Society for Healthcare Epidemiology of America. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 70(3):195–283
Cook DJ, Barbara DW, Singh KE, Dearani JA (2014) Penicillin skin testing in cardiac surgery. J Thorac Cardiovasc Surg 147(6):1931–1935
Plager JH, Mancini CM, Fu X, Melnitchouk S, Shenoy ES, Banerji A, Collier L, Chaudhary N, Yerneni S, Zhang Y, Blumenthal KG (2020) Preoperative penicillin allergy testing in patients undergoing cardiac surgery. Ann Allergy Asthma Immunol 124(6):583–588
Li JT, Markus PJ, Osmon DR, Estes L, Gosselin VA, Hanssen AD (2000) Reduction of vancomycin use in orthopedic patients with a history of antibiotic allergy. Mayo Clin Proc 75(9):902–906
Frigas E, Park MA, Narr BJ, Volcheck GW, Danielson DR, Markus PJ, Olson KE, Schroeder DR, Kita H (2008) Preoperative evaluation of patients with history of allergy to penicillin: comparison of 2 models of practice. Mayo Clin Proc 83(6):651–662
Park M, Markus P, Matesic D, Li JT (2006) Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy. Ann Allergy Asthma Immunol 97(5):681–687
Moussa Y, Shuster J, Matte G, Sullivan A, Goldstein RH, Cunningham D, Ben-Shoshan M, Baldini G, Carli F, Tsoukas C (2018) De-labeling of β-lactam allergy reduces intraoperative time and optimizes choice in antibiotic prophylaxis. Surgery S0039–6060(18):30127–30132
Pagani NR, Moverman MA, Puzzitiello RN, Menendez ME, Barnes CL, Kavolus JJ (2021) Preoperative allergy testing for patients reporting penicillin and cephalosporin allergies is cost-effective in preventing infection after total knee and hip arthroplasty. J Arthroplasty 36(2):700–704
Beltran RJ, Kako H, Chovanec T, Ramesh A, Bissonnette B, Tobias JD (2015) Penicillin allergy and surgical prophylaxis: cephalosporin cross-reactivity risk in a pediatric tertiary care center. J Pediatr Surg 50(5):856–859
Kuruvilla M, Sexton M, Wiley Z, Langfitt T, Lynde GC, Wolf F (2020) A streamlined approach to optimize perioperative antibiotic prophylaxis in the setting of penicillin allergy labels. J Allergy Clin Immunol Pract 8(4):1316–1322
Vaisman A, McCready J, Hicks S, Powis J (2017) Optimizing preoperative prophylaxis in patients with reported β-lactam allergy: a novel extension of antimicrobial stewardship. J Antimicrob Chemother 72(9):2657–2660
Cook E, Ramirez M, Turrentine M (2020) Time has come for routine penicillin allergy testing in obstetrics. AJP Rep 10(1):e15–e19
Desai SH, Kaplan MS, Chen Q, Macy EM (2017) Morbidity in pregnant women associated with unverified penicillin allergies, antibiotic use, and group B Streptococcus infections. Perm J 21:16–080
Fairlie T, Zell ER, Schrag S (2013) Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease. Obstet Gynecol 121(3):570–577
Committee on Practice Bulletins-Obstetrics (2018) ACOG Practice Bulletin No. 199: use of prophylactic antibiotics in labor and delivery. Obstet Gynecol 132(3):e103-e119
Siegel AM, Heine RP, Dotters-Katz SK (2019) The effect of non-penicillin antibiotic regimens on neonatal outcomes in preterm premature rupture of membranes. AJP Rep 9(1):e67–e71
Harris BS, Hopkins MK, Villers MS, Weber JM, Pieper C, Grotegut CA, Swamy GK, Hughes BL, Heine RP (2019) Efficacy of non-beta-lactam antibiotics for prevention of cesarean delivery surgical site infections. AJP Rep 9(2):e167–e171
Hopkins MK, Dotters-Katz S, Boggess K, Heine RP, Smid M (2018) Perioperative antibiotic choice in labored versus unlabored cesareans and risk of postcesarean infectious morbidity. Am J Perinatol 35(2):127–133
Regan JA, Klebanoff MA, Nugent RP (1991) The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group. Obstet Gynecol 77(4):604–10
Campbell JR, Hillier SL, Krohn MA, Ferrieri P, Zaleznik DF, Baker CJ (2000) Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol 96(4):498–503
Sakai-Bizmark R, Ross MG, Estevez D, Bedel LEM, Marr EH, Tsugawa Y (2021) Evaluation of hospital cesarean delivery-related profits and rates in the United States. JAMA Netw Open 4(3):e212235
Goldenberg RL, Culhane JF, Iams JD, Romero R (2008) Epidemiology and causes of preterm birth. Lancet 371(9606):75–84. https://doi.org/10.1016/S0140-6736(08)60074-4
Foxman B, D’Arcy H, Gillespie B, Bobo JK, Schwartz K (2002) Lactation mastitis: occurrence and medical management among 946 breastfeeding women in the United States. Am J Epidemiol 155(2):103–114
Pustotina O (2016) Management of mastitis and breast engorgement in breastfeeding women. J Matern Fetal Neonatal Med 29(19):3121–3125
Macy E (2006) Penicillin skin testing in pregnant women with a history of penicillin allergy and group B streptococcus colonization. Ann Allergy Asthma Immunol 97(2):164–168
Philipson EH, Lang DM, Gordon SJ, Burlingame JM, Emery SP, Arroliga ME (2007) Management of group B Streptococcus in pregnant women with penicillin allergy. J Reprod Med 52(6):480–484
Kuder MM, Lennox MG, Li M, Lang DM, Pien L (2020) Skin testing and oral amoxicillin challenge in the outpatient allergy and clinical immunology clinic in pregnant women with penicillin allergy. Ann Allergy Asthma Immunol 125(6):646–651
Trubiano JA, Slavin MA, Thursky KA, Grayson ML, Phillips EJ (2019) Beta-lactam and sulfonamide allergy testing should be a standard of care in immunocompromised hosts. J Allergy Clin Immunol Pract 7(7):2151–2153
Anstey KM, Lee M, Dawson D, Jue V, Budzik JM, Yu M, Kleinhenz ME, Otani IM (2020) Antibiotic adverse reactions in adult cystic fibrosis patients. J Allergy Clin Immunol Pract 8(10):3631–3633.e1
Chow TG, Khan DA (2021) Sulfonamide hypersensitivity. Clin Rev Allergy Immunol. https://doi.org/10.1007/s12016-021-08872-3
CF Foundation Patient Registry, Annual Data Report 2017. Available at: https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2017-Patient-Registry-Annual-Data-Report.pdf. Accessed 17 April, 2020
Braun C, Reix P, Durieu I, Nove-Josserand R, Durupt S, Ohlmann C, Mainguy C, Nicolas JF, Nosbaum A, Jubin V (2020) The diagnosis of hypersensitivity to antibiotics is rarely confirmed by allergy work-up in cystic fibrosis patients. Pediatr Allergy Immunol 31(4):396–404
Williams AM, Baran AM, Meacham PJ, Feldman MM, Valencia HE, Newsom-Stewart C, Gupta N, Janelsins MC, Barr PM, Zent CS (2018) Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies. Leuk Lymphoma 59(3):625–632
Casazza AR, Duvall CP, Carbone PP (1966) Infection in lymphoma. Histology, treatment, and duration in relation to incidence and survival. JAMA 197(9):710–6
Blimark C, Holmberg E, Mellqvist UH, Landgren O, Björkholm M, Hultcrantz M, Kjellander C, Turesson I, Kristinsson SY (2015) Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients. Haematologica 100(1):107–113
Safdar A, Armstrong D (2011) Infections in patients with hematologic neoplasms and hematopoietic stem cell transplantation: neutropenia, humoral, and splenic defects. Clin Infect Dis 53(8):798–806
Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR (2011) Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52(4):e56–93
Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, Langston AA, Nastoupil LJ, Rajotte M, Rolston K, Strasfeld L, Flowers CR (2018) Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. J Clin Oncol 36(14):1443–1453
Huang KG, Cluzet V, Hamilton K, Fadugba O (2018) The impact of reported beta-lactam allergy in hospitalized patients with hematologic malignancies requiring antibiotics. Clin Infect Dis 67(1):27–33
Modi AR, Majhail NS, Rybicki L, Athans V, Carlstrom K, Srinivas P, Lang DM, Sobecks R, Kovacs CS (2019) Penicillin allergy skin testing as an antibiotic stewardship intervention reduces alternative antibiotic exposures in hematopoietic stem cell transplant recipients. Transpl Infect Dis 21(6):e13175
Imlay H, Krantz EM, Stohs EJ, Lan KF, Zier J, Kim HN, Rakita RM, Limaye AP, Wald A, Pergam SA, Liu C (2020) Reported β-lactam and other antibiotic allergies in solid organ and hematopoietic cell transplant recipients. Clin Infect Dis 71(7):1587–1594
Khumra S, Chan J, Urbancic K, Worland T, Angus P, Jones R, Grayson ML, Trubiano JA (2017) Antibiotic allergy labels in a liver transplant recipient study. Antimicrob Agents Chemother 61(5):e00078-e117
Padmanabhan Menon D, Sacco K, Shalev JA, Narula T, Gonzalez-Estrada A (2019) Safety of penicillin allergy skin testing in patients with low lung volumes before lung transplant. Ann Allergy Asthma Immunol 122(1):122–123
Gutta R, Radojicic C (2012) Safety and effectiveness of penicillin allergy evaluation in the pre-lung transplant patient population. J Allergy Clin Immunol 129(2):S1A-4A
Petri M, Genovese M (1992) Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort. J Rheumatol 19(10):1559–1565
von Maur K, Turk A, Stevens MB, Adkinson NF Jr, Lichtenstein LM (1975) Penicillin hypersensitivity in systemic lupus erythematosus. Int Arch Allergy Appl Immunol 49(4):428–433
Petri M, Allbritton J (1992) Antibiotic allergy in systemic lupus erythematosus: a case-control study. J Rheumatol 19(2):265–269
Mortezavi M, Mustafa SS, Ramsey A (2020) Penicillin skin testing immunocompromised patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Allergy Asthma Immunol 124(3):298–299
UCSF Inpatient Beta-lactam Allergy Guideline. Available at: https://idmp.ucsf.edu/content/inpatient-beta-lactam-allergy-guideline. Accessed 26 July, 2021
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Anstey, K.M., Tsao, L. & Otani, I.M. Drug Allergy Delabeling Programs: Recent Strategies and Targeted Populations. Clinic Rev Allerg Immunol 62, 484–504 (2022). https://doi.org/10.1007/s12016-021-08913-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-021-08913-x